Publication

The following are some of the academic articles which have used MDV data.

Academic Articles

Total number of publications

789

Publication Icon

Search for Articles

The term "full-match search" refers to searching for items that contain all the words entered, while "partial-match search" refers to searching for items that contain even one of the words entered.

~

Search results: 16

Download Publication List

2025

TitleReal-world treatment persistence in csDMARD-IR and bDMARD-IR patients with rheumatoid arthritis in Japan: A large claims database study
AuthorsTsutomu Takeuchi, Craig Pfeifer, Yan Zhong, Yi Piao, Toshihiko Kaise, Mahiro Tani
PublishedModern Rheumatology
Therapeutic AreaRheumatoid arthritis
TitleDevelopment and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan
AuthorsToshihiro Nanki, Tomohiro Yamaguchi, Kosei Umetsu, Ryunosuke Tanabe, Naoki Maeda, Minori Kanazawa, Yuko Furuno, Shinichi Matsuda, Shinya Takemoto, Keiko Asao, Tatsuya Kamiuchi
PublishedClinical Rheumatology
Therapeutic AreaRheumatoid arthritis

2024

TitleIncreased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database
AuthorsRyoko Sakai, Eiichi Tanaka, Eisuke Inoue and Masayoshi Harigai
PublishedRMD Open
Therapeutic AreaRheumatoid arthritis
TitlePOS0953 COMPARING LONG-TERM PERSISTENCE RATES OF SECUKINUMAB OR ADALIMUMAB USING PROPENSITY SCORE MATCHING IN PATIENTS WITH PSORIATIC ARTHRITIS: FINDINGS FROM THE REAL-WORLD FLYWAY STUDY
AuthorsK. Ishii, H. Kameda, J. Kiriyama, T. Mikami, H. Uratsuji, A. Morita
PublishedAnnals of the Rheumatic Diseases
Therapeutic AreaRheumatoid arthritis
TitleDisease-modifying antirheumatic drug selection in Japanese patients with rheumatoid arthritis treated with biologics or JAK inhibitors without methotrexate: A retrospective hospital-based administrative claims database study
AuthorsNaohisa Miyakawa, Katsuki Tsuritani, Bruno Casaes Teixeira, Keishi Fujio
PublishedModern Rheumatology
Therapeutic AreaRheumatoid arthritis
TitleTreatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study
AuthorsMasahiko Miyashiro, Teita Asano, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu & Junya Masuda
PublishedDrugs - Real World Outcomes
Therapeutic AreaRheumatoid arthritis

2023

TitleA Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan
AuthorsMasahiko Miyashiro, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu & Junya Masuda
PublishedRheumatology and Therapy
Therapeutic AreaRheumatoid arthritis
TitleHealthcare resource utilisation and economic burden of patients with adequate and inadequate responses to biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis in Japan
AuthorsKei Ikeda, Yuko Kaneko, Yuki Tsujita, Isao Kawaguchi, Jayeshkumar Patel, Toru Yamazaki, Siran Fang, Yutaka Kawahito
PublishedModern Rheumatology
Therapeutic AreaRheumatoid arthritis

2022

TitleCost-Effectiveness Analyses of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Diseases in Patients With Rheumatoid Arthritis: Three Approaches with a Cohort Simulation and Real-World Data
AuthorsMasataka Kuwana, Naoto Tamura, Shinsuke Yasuda, Keishi Fujio, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Yuichi Kawata, Katsuhisa Yamashita, Ataru Igarashi
PublishedModern Rheumatology
Therapeutic AreaRheumatoid arthritis
TitleUnincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study
AuthorsRyoko Sakai, Eiichi Tanaka, Masako Majima & Masayoshi Harigai
PublishedArthritis Research & Therapy
Therapeutic AreaRheumatoid arthritis
TitleRisk of Hospitalized Infections in Older Elderly Rheumatoid Arthritis Patients Treated with Biological/Targeted Synthetic DMARDs: Evaluation Using Data from a Japanese Claims Database
AuthorsMasayoshi Harigai, Takao Fujii, Ryoko Sakai, Ataru Igarashi, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Amika Yoshida, Norihiro Okada, Katsuhisa Yamashita and Yutaka Kawahito
PublishedModern Rheumatology
Therapeutic AreaRheumatoid arthritis

2020

TitleFRI0075 DECREASED RISKS OF HOSPITALIZED INFECTION UNDER TARGETED THERAPIES VS METHOTREXATE IN ELDERLY AND OLDER ELDERLY PATIENTS COMPARED TO YOUNGER PATIENTS WITH RHEUMATOID ARTHRITIS USING JAPANESE HEALTH INSURANCE DATABASE
AuthorsR. Sakai, E. Tanaka, M. Majima, M. Harigai
PublishedAnnals of the Rheumatic Diseases
Therapeutic AreaRheumatoid arthritis

2019

TitleCo-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach
AuthorsJörg Mahlich, Rosarin Sruamsiri
PublishedInternational Journal for Equity in Health
Therapeutic AreaRheumatoid arthritis

2016

TitleRisk for cardiovascular disease in Japanese patients with rheumatoid arthritis: a large-scale epidemiological study using a healthcare database
AuthorsKunihiko Tanaka, Kenji Hamada, Terumi Nakayama, Shinichi Matsuda, Akihide Atsumi, Tomomi Shimura, Masatomi Nemoto
PublishedSpringerPlus 2016
Therapeutic AreaRheumatoid arthritis
TitleTreatment patterns of rheumatoid arthritis in Japanese hospitals and predictors of the initiation of biologic agents
AuthorsJoerg Mahlich, Rosarin Sruamsiri
PublishedCurrent Medical Research and Opinion 2017
Therapeutic AreaRheumatoid arthritis
TitlePersistence with biologic agents for the treatment of rheumatoid arthritis in Japan
AuthorsJörg Mahlich, Rosarin Sruamsiri
PublishedPatient Prefer and Adherence 2016
Therapeutic AreaRheumatoid arthritis

About Japanese Healthcare System

What you need to know about the healthcare system in Japan before using the data.

SERVICE

In addition to various web tools that allow you to easily conduct surveys via a browser using our medical database, we offer data provision services categorized into four types to meet your needs and challenges: "Analysis reports" "Datasets," "All Therapeutic Areas Data Provision Service," and "Specific Therapeutic Areas Data Provision Service.

page top